EWI2 and its relatives in Tetraspanin-enriched membrane domains regulate malignancy.

Yingjun Ding, Junxiong Chen, Shuping Li, Jonathan D Wren, Akhilesh K Bajpai, Jie Wang, Takemi Tanaka, Heather C Rice, Franklin A Hays, Lu Lu, Xin A Zhang

Oncogene 2023 Mar

filter terms:

Experimental studies on immunoglobulin superfamily (IgSF) member EWI2 reveal that it suppresses a variety of solid malignant tumors including brain, lung, skin, and prostate cancers in animal models and inhibits tumor cell movement and growth in vitro. While EWI2 appears to support myeloid leukemia in mouse models and maintain leukemia stem cells. Bioinformatics analyses suggest that EWI2 gene expression is downregulated in glioblastoma but upregulated in melanoma, pancreatic cancer, and liver cancer. The mechanism of action for EWI2 is linked to its inhibition of growth factor receptors and cell adhesion proteins through its associated tetraspanin-enriched membrane domains (TEMDs), by altering the cell surface clustering and endolysosome trafficking/turnover of these transmembrane proteins. Recent studies also show that EWI2 modulates the nuclear translocation of ERK and TFEB to change the activities of these gene expression regulators. For EWI2 relatives including FPRP, IgSF3, and CD101, although their roles in malignant diseases are not fully clear and remain to be determined experimentally, FPRP and IgSF3 likely promote the progression of solid malignant tumors while CD101 seems to modulate immune cells of tumor microenvironment. Distinctive from other tumor regulators, the impacts of EWI subfamily members on solid malignant tumors are likely to be context dependent. In other words, the effect of a given EWI subfamily member on a tumor probably depends on the molecular network and composition of TEMDs in that tumor. Collectively, EWI2 and its relatives are emerged as important regulators of malignant diseases with promising potentials to become anti-cancer therapeutics and cancer therapy targets. © 2023. The Author(s), under exclusive licence to Springer Nature Limited.

Citation

Yingjun Ding, Junxiong Chen, Shuping Li, Jonathan D Wren, Akhilesh K Bajpai, Jie Wang, Takemi Tanaka, Heather C Rice, Franklin A Hays, Lu Lu, Xin A Zhang. EWI2 and its relatives in Tetraspanin-enriched membrane domains regulate malignancy. Oncogene. 2023 Mar;42(12):861-868